Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) Q4 2024 Earnings Conference Call February 6, 2025 4:30 PM ET Todd Tushla - Vice President of Investor Relations Kyle Gano - Chief Executive Officer Matt ...

Detailed price information for UBS Group Ag ADR (UBS-N) from The Globe and Mail including charting and trades.

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Dogs for the Disabled, a charity started in Cork in 2007 with the aim of training specially bred dogs to assist disabled children and adults to live independent lives, was approached by a former ...

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while revenue slightly missed estimates.

Even under the best of circumstances, remembering to take a daily pill can be a challenge. For someone living with ...

The elderly are more susceptible to pneumonia than younger populations. The prevalence of both disability and comorbid diseases increase with age and are associated with increased risk of pneumonia.

In addition to its widely recognized effects on gait, posture, balance, and upper limb coordination, Parkinson's disease (PD) can have a profound effect on speech and voice, within a cluster of ...

Service specifications are important in clearly defining the standards of care expected from organisations funded by NHS England to provide specialised care. The specifications have been developed by ...

Does the 2012 Holden Calais V VE Series II V6 live up to the nameplate and the statement made by the most luxurious Commodore variant? With the new 2012 VE Series II model you’d expect some ...

It might be a humble truck from Holden, but does the 2012 Holden Commodore Ute SS VE Series II have another personality? Is it also one of the best value two-door performance cars around?